Osteoporosis Management in Women Who Had a Fracture

Identifying Attributes

Care Settings
Primary Care
Country
United States of America
Publishing Organisation
public reporting, Quality Improvement with Benchmarking (external benchmarking to multiple organizations), Regulatory and Accreditation Programs
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Preventive Care

Defining Attributes

Definition

The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.

Numerator

Patients who received either a bone mineral density test or a prescription for a drug to treat osteoporosis after a fracture occurs.

Denominator

Women who experienced a fracture, except fractures of the finger, toe, face or skull.

Exclusions

Exclude women who had a bone mineral density test during the 24 months prior to the index fracture. - Exclude women who had a claim/encounter for osteoporosis treatment during 12 months prior to the index fracture. - Exclude women who received a dispensed prescription or had an active prescription to treat osteoporosis during the 12 months prior to the index fracture. - Exclude women who are enrolled in a Medicare Institutional Special Needs Plan (I-SNP) or living long-term in an institution any time during the measurement year. - Exclude women receiving hospice care during the measurement year.

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

By age group: 50-64, 65-85, 50-85

Collection and Reporting Attributes

Type of Data Collection
Administrative data, Electronic/paper chart records
Data Collection Methods

Registry data

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
Yes
Australian Consortium for Aged Care Endorsed
Yes
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025